FIT Recommendations

The Forum for Injection Technique (FIT) was developed to establish and promote best practice in injection technique for all involved in diabetes care and the founding members are experienced diabetes specialist nurses.

The key aims are to raise awareness of existing and emerging research relating to injection technique and the impact this may have on health outcomes for those with diabetes that require subcutaneous injection therapy.

FIT was established following the publication of the international New injection recommendations for patients with diabetes, (Diabetes & Metabolism 2010). These are the first Irish recommendations for Injection Technique. These recommendations are adapted from the First UK FIT Injection Technique Recommendations 2nd Edition 2010.

Diabetes is a major chronic illness, with type 2 diabetes affecting 1 in 20 people in Ireland¹. It is estimated that 180,000 people, of all age groups, in Ireland have either type 1 or type 2 diabetes, and this is
expected to rise to 233,000 by 2020². Recent research conducted by Diabetes Ireland shows that one in three people has a family member with diabetes³.

The cost of diabetes care is becoming an increasing burden for the Irish Health Service Executive. Diabetes treatment and complications make up to 5% of Irish national health expenditure.⁴

It is estimated that almost 30% of people with diabetes use injectable therapies,⁵ which, based on current figures, can be calculated as approximately 54,000 Irish people. For injectable therapies to work optimally, correct injection technique is essential and, therefore, an improvement in technique could potentially contribute to managing the cost of diabetes care.

FIT is an autonomous organisation whose mission is to support people with diabetes requiring injectable therapies in achieving the best possible health outcomes, by ensuring that the correct dose is delivered to the correct injection site, using the correct technique, each and every time.

The development of FIT and the subsequent Irish recommendations for injection technique have been supported by BD Europe and endorsed by various bodies in Ireland including pharmaceutical companies whose therapies include subcutaneous injections of insulin and GLP-1 agonists.

FIT is committed to supporting the implementation of the recommendations by all those involved in diabetes care. These recommendations will be updated at regular intervals to include new research evidence as it emerges. We therefore welcome any comments, suggestions and active participation in ensuring that the recommendations remain relevant and useful for now and the future.

Helen Twamley
Clinical Nurse Manager 2 Chair
Sonya Browne
Clinical Nurse Specialist
Helen Burke
Advanced Nurse Practitioner
Patricia Coady
Clinical Nurse Specialist
Yvonne Moloney
Clinical Midwife Specialist

 

¹Health Service Executive, Review of Diabetes Structured Education, Republic of Ireland 2009
http://www.hse.ie/eng/services/Publications/topics/Diabetes/diabetesstructureded.pdf
²Source: Irish Times, Diabetes at crisis level in Ireland, new figures confirm (October 4th 2011)
http://www.irishtimes.com/newspaper/health/2011/1004/1224305196665.html
³Source: Diabetes Federation of Ireland, One in three families affected by diabeteshttp://www.diabetes.ie/2011/10/03/know-your-numbers/
⁴Health Service Executive, Review of Diabetes Sructured Education, Republic of Ireland 2009
⁵Diabetes inhaler rejected for NHS, BBC News, 19 April 2006

Reference this report as: FIT Ireland 2012; The First Irish Injection Technique Recommendations 1st Edition http://fit4diabetes.com/ireland/

 Download full FIT Recommendations here arrow_right.png